Results 111 to 120 of about 77,670 (298)

Progress in research on osteoporosis secondary to SARS‐CoV‐2 infection

open access: yesAnimal Models and Experimental Medicine, EarlyView.
This review explores the potential mechanisms, complications, risk factors, and future research directions related to osteoporosis secondary to SARS‐CoV‐2 infection. Key mechanisms include an imbalance between osteoclast and osteoblast activity driven by direct viral effects on bone, inflammation, hypoxia, dysregulation of noncoding RNAs, and metabolic
Jinlong Wang   +5 more
wiley   +1 more source

Microscopic observations of SARS‐CoV‐2 like particles in different oral samples

open access: yesEuropean Journal of Oral Sciences, Volume 130, Issue 6, December 2022., 2022
Abstract The emerging coronavirus pneumonia epidemic caused by the SARS‐CoV‐2 infection has spread rapidly around the world. The main routes of transmission of SARS‐CoV‐2 are currently recognised as aerosol/droplet inhalation. However, the involvement of the oral cavity in coronavirus disease 2019 (COVID‐19) is poorly known.
Djamal Brahim Belhaouari   +5 more
wiley   +1 more source

Nutraceuticals and COVID‐19: A mechanistic approach toward attenuating the disease complications

open access: yesJournal of Food Biochemistry, Volume 46, Issue 12, December 2022., 2022
Abstract Nutraceuticals have emerged as potential compounds to attenuate the COVID‐19 complications. Precisely, these food additives strengthen the overall COVID treatment and enhance the immunity of a person. Such compounds have been used at a large scale, in almost every household due to their better affordability and easy access.
Keshav Raj Paudel   +19 more
wiley   +1 more source

Adverse events associated with monoclonal antibodies used for treatment of COVID‐19: A systematic review and meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This review aimed to synthesise the evidence related to the incidence of serious and non‐serious adverse events with the use of monoclonal antibodies (mAbs) among COVID‐19 patients. Methods Databases were searched from January 2020 to September 2023 for randomized clinical trials (RCTs) that used mAbs for the treatment of COVID‐19 regardless of ...
Htet Htet   +6 more
wiley   +1 more source

Respiratory and systemic monocytes, dendritic cells, and myeloid‐derived suppressor cells in COVID‐19: Implications for disease severity

open access: yesJournal of Internal Medicine, Volume 293, Issue 2, Page 130-143, February 2023., 2023
Abstract Since the beginning of the SARS‐CoV‐2 pandemic in 2020, researchers worldwide have made efforts to understand the mechanisms behind the varying range of COVID‐19 disease severity. Since the respiratory tract is the site of infection, and immune cells differ depending on their anatomical location, studying blood is not sufficient to understand ...
Sara Falck‐Jones   +2 more
wiley   +1 more source

Comparing the binding interactions in the receptor binding domains of SARS-CoV-2 and SARS-CoV [PDF]

open access: yesarXiv, 2020
COVID-19, since emerged in Wuhan, China, has been a major concern due to its high infection rate, leaving more than one million infected people around the world. Huge number of studies tried to reveal the structure of the SARS-CoV-2 compared to the SARS-CoV-1, in order to suppress this high infection rate.
arxiv  

Terminal Antennas in ACE2

open access: yesRadioengineering, 2008
The ACE Network of Excellence was a European Commission funded Network of Excellence, which lasted from 2004 to 2007. One of the activities performed by this Network was in the frame of terminal antennas. In this activity, three aspects were covered in three projects: Small antenna technologies, small terminal antenna technologies and benchmarking of ...
Martinez-Vasquez, M.   +3 more
openaire   +3 more sources

Liver organoids: From 3D printing to biomedical applications

open access: yesBMEMat, EarlyView.
A comprehensive review on liver organoids culture techniques from 3D printing to organ‐on‐chip, as well as focusing on challenges and perspectives for advancement liver organoids in various future applications. Abstract The liver is an immune organ, especially an immune tolerance organ.
Ying Shi   +4 more
wiley   +1 more source

Glycosylation and the global virome

open access: yesMolecular Ecology, Volume 32, Issue 1, Page 37-44, January 2023., 2023
Abstract The sugars that coat the outsides of viruses and host cells are key to successful disease transmission, but they remain understudied compared to other molecular features. Understanding the comparative zoology of glycosylation ‐ and harnessing it for predictive science ‐ could help close the molecular gap in zoonotic risk assessment.
Cassandra L. Pegg   +4 more
wiley   +1 more source

Are new genome variants detected in SARS-CoV-2 expected considering population dynamics in viruses?

open access: yesThe EuroBiotech Journal, 2021
The pandemic COVID-19 is caused by a highly transmissible severe acute respiratory coronavirus 2 (SARS-CoV-2) which showed the highest morbidity and mortality rates among the other coronavirus infections such as SARS-CoV and MERS-CoV.
Ergoren Mahmut Cerkez   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy